News

The State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection violations related to the ...
PORTLAND, OR, UNITED STATES, June 20, 2025 /EINPresswire.com/ -- The global nicotine replacement therapy (NRT) market is ...
Pfizer has joined the ranks of companies developing cancer drugs that target both PD-1 and VEGF – one of the hottest drug classes in oncology, via a $6 billion licensing deal with China's 3SBio.